sorafenib has been researched along with nocodazole in 2 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (nocodazole) | Trials (nocodazole) | Recent Studies (post-2010) (nocodazole) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 3,078 | 0 | 655 |
| Protein | Taxonomy | sorafenib (IC50) | nocodazole (IC50) |
|---|---|---|---|
| Chain A, Glutathione-requiring prostaglandin D synthase | Homo sapiens (human) | 65 | |
| nuclear receptor subfamily 0 group B member 1 | Homo sapiens (human) | 0.8334 | |
| Tyrosine-protein kinase ABL1 | Homo sapiens (human) | 0.64 | |
| Tubulin alpha-1A chain | Sus scrofa (pig) | 1.3775 | |
| Tubulin beta chain | Sus scrofa (pig) | 0.76 | |
| Tubulin beta-4A chain | Homo sapiens (human) | 1.2975 | |
| Tubulin beta chain | Homo sapiens (human) | 1.2975 | |
| Tubulin alpha-3C chain | Homo sapiens (human) | 1.2975 | |
| Adenosine receptor A2a | Homo sapiens (human) | 7.509 | |
| Tubulin alpha-1B chain | Homo sapiens (human) | 1.2975 | |
| Tubulin alpha-4A chain | Homo sapiens (human) | 1.2975 | |
| Tubulin beta-4B chain | Homo sapiens (human) | 1.2975 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 6.232 | |
| Tubulin beta-3 chain | Homo sapiens (human) | 1.2975 | |
| Tubulin beta-2A chain | Homo sapiens (human) | 1.2975 | |
| Tubulin beta-8 chain | Homo sapiens (human) | 1.2975 | |
| Tubulin beta-2B chain | Bos taurus (cattle) | 2.3 | |
| Tubulin alpha-3E chain | Homo sapiens (human) | 1.2975 | |
| Tubulin alpha-1A chain | Homo sapiens (human) | 1.2975 | |
| Similar to alpha-tubulin isoform 1 | Bos taurus (cattle) | 2.3 | |
| Similar to alpha-tubulin isoform 1 | Bos taurus (cattle) | 2.3 | |
| Tubulin alpha-1C chain | Homo sapiens (human) | 1.2975 | |
| Tubulin beta-6 chain | Homo sapiens (human) | 1.2975 | |
| Tubulin beta-2B chain | Homo sapiens (human) | 1.2975 | |
| Tubulin beta-1 chain | Homo sapiens (human) | 1.2975 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Y; Xu, Z; Zhao, SJ | 1 |
| Alsaghir, FM; El-Gamal, MI; Sbenati, RM; Semreen, AM; Semreen, MH; Shehata, MK | 1 |
2 review(s) available for sorafenib and nocodazole
| Article | Year |
|---|---|
1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships.
Topics: Antineoplastic Agents; Humans; Molecular Structure; Neoplasms; Structure-Activity Relationship; Triazoles | 2019 |
Evaluation of imidazo[2,1-b]thiazole-based anticancer agents in one decade (2011-2020): Current status and future prospects.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; ErbB Receptors; Humans; Imidazoles; Models, Molecular; Protein Binding; Protein Kinase Inhibitors; Ribosomal Protein S6 Kinases, 90-kDa; Signal Transduction; Structure-Activity Relationship; Thiazoles; Tubulin | 2021 |